129 related articles for article (PubMed ID: 25675617)
1. [PAL-1 5G/4G polymorphism in patients with systemic lupus erythematosus].
Savov A; Andonova S; Tanev D; Robeva R; Marincheva Ts; Tomova A; Kumanov P; Rashkov R; Kolarov Z
Akush Ginekol (Sofiia); 2014; 53(7):13-7. PubMed ID: 25675617
[TBL] [Abstract][Full Text] [Related]
2. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
[TBL] [Abstract][Full Text] [Related]
3. The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome.
Tàssies D; Espinosa G; Muñoz-Rodríguez FJ; Freire C; Cervera R; Monteagudo J; Maragall S; Escolar G; Ingelmo M; Ordinas A; Font J; Reverter JC
Arthritis Rheum; 2000 Oct; 43(10):2349-58. PubMed ID: 11037896
[TBL] [Abstract][Full Text] [Related]
4. Genotype Ser413/Ser of PAI-2 polymorphism Ser413/Cys is associated with anti-phospholipid syndrome and systemic lupus erythematosus in a familial case: comparison with healthy controls.
Vázquez-Del Mercado M; García-Cobian TA; Muñoz Valle JF; Torres-Carrillo N; Martín-Márquez BT; Arana-Argaez VE; Best-Aguilera CR; Martínez-García EA; Petri MH; Núñez-Atahualpa L; Delgado-Rizo V
Scand J Rheumatol; 2007; 36(3):206-10. PubMed ID: 17657675
[TBL] [Abstract][Full Text] [Related]
5. [Reproductive problems in women with PCOS, the impact of PAI-1 carriers of 4G PAI-1 polymorphism and BMI].
Komsa-Penkova R; Golemanov G; Georgieva G; Popovski K; Slavov N; Ivanov P; Kovacheva K; Atanasova M; Blajev A
Akush Ginekol (Sofiia); 2014; 53(6):15-21. PubMed ID: 25672133
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion.
Schenk JF; Stephan B; Zewinger S; Speer T; Pindur G
Clin Hemorheol Microcirc; 2008; 39(1-4):329-32. PubMed ID: 18503142
[TBL] [Abstract][Full Text] [Related]
7. [Polymorphism of the plasminogen activator inhibitor type 1 gene, plasminogen level and thrombosis in patients with antiphospholipid syndrome].
Aĭsina RB; Mukhametova LI; Ostriakova EV; Seredavkina NV; Patrushev LI; Patrusheva NL; Reshetniak TM; Gulin DA; Gershkovich KB; Nasonov EL; Varfolomeev SD
Biomed Khim; 2014; 60(1):72-93. PubMed ID: 24749249
[TBL] [Abstract][Full Text] [Related]
8. The -675 4G/5G
Anaya-Macias BU; De la Cruz-Mosso U; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla G; González-López L; Gámez-Nava JI; Pérez-Guerrero EE; Barrientos-Avalos SL; Muñoz-Valle JF
Autoimmunity; 2020 Mar; 53(2):71-77. PubMed ID: 31829037
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity.
Gilabert-Estellés J; Ramón LA; Braza-Boïls A; Gilabert J; Chirivella M; España F; Estellés A
Thromb Res; 2012 Aug; 130(2):242-7. PubMed ID: 22055623
[TBL] [Abstract][Full Text] [Related]
10. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of allelic variants affecting the hemostatic system in the development of antiphospholipid syndrome and kidney lesion in patients with systemic lupus erythematosus].
Borisov EN; Krasnova TN; Samohodskaia LM; Ivanitskiĭ LV; Nikiforova NV; Mukhin NA
Ter Arkh; 2014; 86(6):57-62. PubMed ID: 25095657
[TBL] [Abstract][Full Text] [Related]
12. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A
Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980
[TBL] [Abstract][Full Text] [Related]
14. [Plasminogen activator inhibitor type 1 activity in women with unexplained very early recurrent pregnancy loss].
Ivanov P; Komsa-Penkova R; Ivanov I; Konova E; Kovacheva K; Simeonova M; Tanchev S
Akush Ginekol (Sofiia); 2010; 49(5):3-8. PubMed ID: 21268395
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
Guan LX; Du XY; Wang JX; Wang RL; Wu ZL; Jiang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):173-5. PubMed ID: 15079805
[TBL] [Abstract][Full Text] [Related]
16. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
Ramón LA; Gilabert-Estellés J; Cosín R; Gilabert J; España F; Castelló R; Chirivella M; Romeu A; Estellés A
Thromb Res; 2008; 122(6):854-60. PubMed ID: 18423526
[TBL] [Abstract][Full Text] [Related]
19. Association between the PAI-1 4G/5G Gene Polymorphism and the Risk of Systemic Lupus Erythematosus/Lupus Nephritis.
Li W; Mao S; Wu L; Shi W; Zhang J; Wang Z
Crit Rev Eukaryot Gene Expr; 2019; 29(1):85-94. PubMed ID: 31002598
[TBL] [Abstract][Full Text] [Related]
20. [Reproductive problems in women with PCOS, the impact of PAL-1 CARRIERS OF 4G PAI -1 polymorphism and BMI].
Komsa-Penkova R; Golemanov G; Georgieva G; Slavov N; Popovski K; Ivanov P; Kovacheva K; Atanasova M; Blajev A
Akush Ginekol (Sofiia); 2014; 53(5):3-9. PubMed ID: 25558663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
